Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Health And Human Services was posted on July 17, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Analytical Services Center for Medications Development Program

Awarded
75N98026D00031Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
APEX Arsenal Solutions Marketplace
Solicitation # HQ0034-27-S-CAPX
The APEX Arsenal Solutions Marketplace (AASM) is a long-term open call initiated by the Department of War (DoW) Office of Industrial Base Growth, managed by the Applied Research Institute and supported by the Washington Headquarters Services Acquisition Directorate. This initiative seeks to identify and curate hardware, software, systems, and workforce development solutions that strengthen the defense industrial base and close critical capability gaps for the Warfighter. The program focuses on the development, scaling, and sustainment of emerging technologies and critical materials, making these solutions available for procurement through rapid acquisition pathways. The submission window runs from December 1, 2026, through November 30, 2027, with submissions collected in monthly cycles. Applicants must submit an unclassified .mp4 video no longer than five minutes and a completed submission form detailing their organization name, Unique Entity Identifier (UEI), and Technology Readiness Level (TRL). Submissions are evaluated by a peer panel of subject matter experts and a Government Selecting Official based on the clarity of the problem description, the strength of the proposed solution, the degree of technological advancement over current capabilities, and the viability of the business model. To maintain integrity, strict organizational conflict of interest protocols are in place, prohibiting assessors from evaluating their own technologies or those in which they hold a financial interest.
Washington Headquarters Services

POSTED

about 16 hours ago

DEADLINE

in about 1 year
NAICS: 541715
New
Federal
Missile Defense Agency - NOBLE Announcement: Machine Aided Software Modernization (MASM)
Solicitation # HQ0860-27-S-C011
The Missile Defense Agency (MDA) is seeking innovative industry solutions for its Next Generation Software Office (NGSW) through the Machine Aided Software Modernization (MASM) solicitation, number HQ0860-27-S-C011. The objective is to drive digital transformation and technology integration within the Missile Defense System, specifically focusing on the development of AI/ML-driven tools for automated code translation and refactoring of legacy code, SI-driven security vulnerability identification and remediation, automated testing and verification of machine-generated code, and seamless DevSecOps integration with DoD and MDA software factories. The effort requires strict compliance with DoD cybersecurity frameworks, including CMMC and NIST SP 800-171, and involves secure interfacing with both classified and unclassified systems. This is a two-step competitive process. Step-one requires the submission of a white paper, a Rough Order of Magnitude cost estimate, and a program summary quad chart by December 17, 2026. White papers are evaluated based on technical achievement, research capabilities, and program management, with a strong emphasis on scientific merit, innovation, and alignment with DoD priorities. Step-two involves negotiations for an award, which may be a FAR-based procurement contract or an Other Transaction (OT) Agreement. Eligible respondents include large and small businesses, non-traditional defense contractors, non-profit organizations, and accredited educational institutions. All offerors must be registered in the System for Award Management (SAM) and must disclose any organizational conflicts of interest or the use of foreign nationals.
Missile Defense Agency (mda)

POSTED

about 16 hours ago

DEADLINE

in 30 days
NAICS: 541715
New
Federal
Altered B Proposers Day
Solicitation # DARPA-SN-27-20
The Altered B Proposers Day, issued by the Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office under solicitation DARPA-SN-27-20, is an informational event designed to introduce the research community to the Altered B program vision. The program seeks foundational breakthroughs in altermagnetism to enable revolutionary low-power electronic and computational capabilities for defense and civilian applications. The effort is divided into two primary focus areas: Materials Synthesis, Processing, and Characterization, which focuses on the discovery and scaling of altermagnetic materials, and Integration and Device Fabrication, which focuses on developing functional hardware demonstrators. Key target prototypes include magnetoresistive RAM (MRAM), high-frequency signal processors, and neuromorphic computing components. This event is not a formal solicitation for proposals or abstracts, and a formal Program Announcement is anticipated for release in December 2026 via sam.gov. The Proposers Day is open to U.S. citizens, permanent residents, and foreign nationals, with specific identity verification and official visit requirements for foreign government officials. Interested parties may submit a single PDF slide for a Lightning Talk by noon on December 2, 2026, provided the content is appropriate for public release. All attendees must present valid government-issued photo identification for physical entry. Technical and administrative inquiries are directed to Program Manager Keith Whitener at [email hidden].
Defense Advanced Research Projects Agcy

POSTED

about 16 hours ago

DEADLINE

in 20 days

AI Contract Overview

Show more

On July 17, 2022, the National Institute on Drug Abuse under the Department of Health and Human Services awarded Contract No. 75N98026D00031 to MRIGlobal to establish and operate the Analytical Services Center for Medications Development. This award, made in response to Solicitation 75N95024R00032, is not a request for quotes or proposals but a formal notice of contract issuance. The contract will be executed over a five-year period through the issuance of task orders and will utilize a hybrid funding structure combining Cost Plus Fixed Fee and Firm Fixed Price mechanisms to support the full scope of analytical services required. The primary place of performance is in Bethesda, Maryland, with all activities centered around advancing medications development through rigorous analytical support. The contract is managed by the National Institutes of Health’s NIDA office located at 9800 Medical Center Drive, Bethesda, MD, 20892. Primary point of contact is Shaun Rostad, reachable at [phone hidden] or [email hidden], with secondary support provided by Josh Lazarus at [phone hidden] or [email hidden]. The North American Industry Classification System code for this contract is 541715, indicating the nature of the work as research and development in the physical, engineering, and life sciences. The contract was posted on SAM.gov on July 17, 2026, and all performance, reporting, and administrative functions are to be conducted in alignment with federal acquisition regulations and NIDA-specific program objectives.

General Info

NIDA awards MRIGlobal five-year contract for analytical services in Bethesda using hybrid funding.

Contract Value

$0

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Bethesda, MD, USA

Set-Aside

NONE

Awardee

MRIGLOBAL

Award Issued Date

Contract End Date

July 20, 2026

Documents

0

No documents available

This contract was awarded without public documents.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • Research and Technical Analysis for Test SystemsOpen now, due in 17 days
  • Altermagnetic Material CharacterizationOpen now, due in 21 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida
Contacts2 people available
OfficeBethesda, MD, 20892, USA

Full Description

Show more

NOTICE OF AWARD. THIS IS NOT A REQUEST FOR QUOTE/PROPOSALS.


On July 17, 2022; in response to the requirements of Solicitation 75N95024R00032, the National Institute on Drug Abuse (NIDA) awarded Contract No. 75N98026D00031 to MRIGlobal for the Analytical Services Center for Medications Development . NIDA anticipates the use of Task Orders with an ultimate Period of Performance of five (5) years. An award shall be made on a Cost Plus Fixed Fee and Firm Fixed Price basis.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

NAICS: 325411
New
Federal
Reagent Generation for Bioanalytical Method Development on Biologics Therapeutics
Solicitation # 75N98027R00020
The National Center for Advancing Translational Sciences within the National Institutes of Health has issued a Sources Sought notice for an IDIQ contract focused on reagent generation for bioanalytical method development on biologics therapeutics. The primary objective is to identify qualified sources capable of generating and delivering high-affinity, specific anti-drug antibodies, including neutralizing antibodies and antibodies against carriers or gene-of-interest protein products. These reagents will support the quantification of novel biologic drugs in biological matrices such as plasma, serum, and tissue homogenates. The anticipated scope includes the production of polyclonal and monoclonal antibodies, specificity characterization, and the delivery of purified antibodies at an estimated scale of 10 to 50 mg per reagent. The required performance standards are rigorous, demanding adherence to US FDA current Good Manufacturing Practice, Good Laboratory Practice, and Good Clinical Practice, as well as ICH and ISO regulations. Contractors must maintain a comprehensive Quality Management Plan and an independent Quality Assurance Unit to ensure all products meet strict quality requirements. Additional requirements include the development of standard operating procedures for packaging and shipping, the maintenance of secure facilities with restricted access, and the implementation of contingency plans for catastrophic events. The anticipated period of performance for this effort is ten years. Interested respondents must be registered in the System for Award Management and provide a capability statement under NAICS code 325411 by November 30, 2026.
Medicinal and Botanical Manufacturing

POSTED

1 day ago

DEADLINE

in 13 days
View Details
NAICS: 541715
Federal
Synthesis and Distribution of Drugs of Abuse and Related Compounds
Solicitation # 75N98027R00006OT
The National Institute on Drug Abuse (NIDA) is issuing a Sources Sought Notice to identify qualified business organizations capable of supporting the synthesis and distribution of drugs of abuse and related compounds. This is not a solicitation for proposals, but a market research effort to determine the availability of technically capable commercial or non-commercial sources and to identify the appropriate acquisition method. The scope of work involves producing, acquiring, and maintaining an inventory of labeled and unlabeled chemical substances, ensuring purity levels of at least 95 percent, and managing the secure storage and shipment of these compounds to research investigators. Interested vendors must demonstrate the ability to handle large quantities of DEA controlled and uncontrolled substances, including peptides, narcotics, and stimulants, some of which require refrigeration. A mandatory requirement for any capable vendor is the possession of a DEA Research Registration for Schedules II through V and the ability to obtain registration for Schedule I substances. Organizations must submit a capability statement of no more than ten pages, including their UEI number, business size, and detailed evidence of staff expertise and prior experience, to the designated Contract Specialist by November 20, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

20 days ago

DEADLINE

in 3 days
View Details
NAICS: 541715
Federal
Synthesis and Distribution of Drugs of Abuse and Related Compounds
Solicitation # 75N98027R00006SB
The National Institute on Drug Abuse (NIDA) is issuing a Small Business Sources Sought Notice to identify qualified small business organizations capable of supporting the synthesis and distribution of drugs of abuse and related compounds. This is a market research effort to determine the availability of technically capable sources and to decide if a small business set-aside is appropriate under NAICS code 541715. The scope of work includes producing, acquiring, and maintaining an inventory of labeled and unlabeled chemical substances, testing for purity, managing the Drug Inventory Supply Control System (DISCS), and ensuring the secure storage and shipment of compounds to research investigators. Interested vendors must demonstrate the ability to store large quantities of DEA-controlled and uncontrolled substances, including peptides, while maintaining a purity level of at least 95 percent. A mandatory requirement for this effort is that vendors possess a DEA Research Registration for Schedules II through V and show the capability to obtain registration for Schedule I substances. Qualified small businesses must submit a capability statement, limited to ten pages, to the designated contract specialist by November 20, 2026. This notice is for information purposes only and does not constitute a solicitation or a commitment to award a contract.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

20 days ago

DEADLINE

in 3 days
View Details
NAICS: 541690
Federal
Modification to Extend Services for Scientific, Operations and Administrative Resources (SOAR) Contract Program
Solicitation # OLAO-SSD-SOAR-NOI
The National Institutes of Health (NIH) intends to negotiate and award non-competitive modifications to extend the Scientific, Operations and Administrative Resources (SOAR) contract program. This program consists of five indefinite-delivery, indefinite-quantity (IDIQ) contracts held by Axle Informatics LLC, Gap Solutions Inc., Kelly Services Inc., Guidehouse Digital LLC, and 22nd Century Technologies Inc. The primary objective is to ensure continuity of specialized scientific professional services across 29 NIH organizations, including the Office of the Director, 27 Institutes and Centers, and ARPA-H, while the agency finalizes a strategic procurement consolidation effort and a competitive follow-on acquisition. The proposed extension includes a basic ordering period from June 22, 2026, to June 21, 2027, with two optional six-month extensions extending through June 21, 2028. Additionally, the government seeks to revise FAR 52.216-22 to allow task orders to extend up to 36 months beyond the parent contract end date. While the combined maximum contract ordering value remains unchanged at $3,600,713,546, the estimated total dollar value for orders through the end of the extension is $2,174,615,674. The government projects the award of these modifications in April 2026. The SOAR program provides critical scientific staffing, such as bioinformatics scientists and molecular biologists, to support biomedical research and public health missions. The NIH has cited a critical need for these specific contract holders to avoid disruptions to ongoing research and patient diagnostics. Interested parties may submit capability statements and pricing information by March 5, 2027, although the government currently intends to proceed on a non-competitive basis with the existing holders.
Other Scientific and Technical Consulting Services

POSTED

9 months ago

DEADLINE

in 4 months
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Get AI-powered intelligence on the opportunities still open

Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS